UBS Reiterates Neutral Rating on IDEXX Laboratories (IDXX)

UBS analyst Andrea Alfonso reiterated a Neutral rating and $730.00 price target on IDEXX Laboratories (NASDAQ: IDXX).

The analyst commented, "We spoke with IDEXX this week ahead of quarter end; management noted that the company is well positioned to navigate the current dynamic environment, including geopolitical issues. That said, one major takeaway is that fuel costs represent a relatively small portion of the overall cost structure, though impacts are felt immediately given fuel’s linkage to spot pricing (labor, by and large, remains the largest contributor to product costs)."

For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.

Shares of IDEXX Laboratories closed at $578.51 yesterday.

You May Also Be Interested In

• Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
• Morgan Stanley Downgrades BioMerieux (BIM:FP) (BMXMF) to Underweight
• Jefferies Reinstates Talen Energy (TLN) at Hold